Aphria Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry & Marijuana Business Briefs International Marijuana Business News Marijuana Stocks & Publicly Traded Cannabis Companies Tilray

Aphria, Tilray to host April shareholder meetings about planned merger

Aphria and Tilray will host special shareholder meetings next month on the proposed merger between the cannabis producers, the companies said. The meetings will be held via live audio webcast for Aphria and Tilray shareholders on April 14 and April 16,…

Aphria aurora cannabis Canada Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry & Marijuana Business Briefs Canopy Growth International Marijuana Business News Tilray

Canada extends wage subsidy popular with cannabis producers

Canada’s government is extending a pandemic-related wage subsidy program that has been tapped by over a dozen federally-regulated cannabis producers. The Canada Emergency Wage Subsidy (CEWS) program, which subsidizes wages for employers which hav…

Aphria Canadian Medical Marijuana & Cannabis Industry News Featured Marijuana Business & Cannabis Industry News International Marijuana Business News Marijuana Stocks & Publicly Traded Cannabis Companies Tilray United States Cannabis Industry & Marijuana Business News

Aphria-Tilray cannabis merger talks overcame pandemic pause, rival bidder and other hurdles, proxy reveals

On-again, off-again merger talks between rival cannabis producers Tilray and Aphria had their genesis in October 2019 when an unidentified investment bank active in the marijuana space pitched a meeting between the company’s respective CEOs, acco…

Aphria Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry & Marijuana Business Briefs Europe Cannabis Industry & Marijuana Business News International Marijuana Business News Marijuana Cultivation News Marijuana Stocks & Publicly Traded Cannabis Companies Tilray United States Cannabis Industry & Marijuana Business News

Canadian marijuana producer Tilray reports $271 million loss for year

Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British Columbia company’s $321 million loss in 2019, according to the full-year and fourth-quarter results released Wednesday. Tilray, which is on …

aurora cannabis Cannabis Growth Fund Cannabusiness Canopy Growth Featured finance investing investors Korey Bauer Maxine Waters medmen stock Tilray WallStreetBets

Wall Street Disruptors Fuel Cannabis Investor Flameout

Wall Street Disruptors Fuel Cannabis Investor Flameout
It seems like the cannabis industry just has not found its mojo.
The post Wall Street Disruptors Fuel Cannabis Investor Flameout appeared first on The Fresh Toast.

ATB Capital Markets Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry Extraction News Cannabis Industry Science News Cronos David Kideckel Europe Cannabis Industry & Marijuana Business News farming Featured Marijuana Business & Cannabis Industry News International Marijuana Business News Marijuana Cultivation News Nextleaf Solutions organigram Shoppers Drug Mart Tilray United States Cannabis Industry & Marijuana Business News

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…

ATB Capital Markets Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry Extraction News Cannabis Industry Science News Cronos David Kideckel Europe Cannabis Industry & Marijuana Business News farming Featured Marijuana Business & Cannabis Industry News International Marijuana Business News Marijuana Cultivation News Nextleaf Solutions organigram Shoppers Drug Mart Tilray United States Cannabis Industry & Marijuana Business News

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…

aurora cannabis Canadian Medical Marijuana & Cannabis Industry News Canopy Growth farming Featured Marijuana Business & Cannabis Industry News health canada International Marijuana Business News Marijuana Cultivation News Marijuana Industry Statistics, Data and Charts Tilray

Canada’s ‘croptober’ surge pushes cannabis inventory over 1 million kilograms

Canadian licensed producers added a record 220,461 kilograms of marijuana to their inventories in October 2020, according to new data offering a statistical glimpse of the country’s first large-scale “croptober” – when most of the fall outd…

Aphria Aphria earnings Canadian Medical Marijuana & Cannabis Industry News cannabis earnings Cannabis Industry & Marijuana Business Briefs Canopy Growth International Marijuana Business News Marijuana Legalization and Regulatory News for Cannabis Businesses quarterly report Recreational Marijuana News Tilray United States Cannabis Industry & Marijuana Business News

Aphria grows Q2 revenue, reports CA$120.6M net loss

Canadian cannabis company Aphria reported increased quarterly revenue on Thursday for the quarter ended Nov. 30, with a net loss of 120.6 million Canadian dollars ($95.3 million). The Ontario-based firm posted net revenue of CA$160.5 million, a 10% inc…

Andrew Cuomo aurora cannabis Chuck Schumer Congress decriminalization descheduling finance Jon Ossoff Kamala Harris Marijuana Legislation Mitch McConnell MORE Act Music Raphael Warnock Senate stocks Tilray

Investment Analysts: What Democratic Senate Means For Federal Marijuana Legalization

Investment Analysts: What Democratic Senate Means For Federal Marijuana Legalization
Leading investment analysts predict that cannabis stocks will soar big time following last week’s Democratic takeover of the U.S. Senate.
The post Investment Analysts:…